Thieler Law Corp, member of the Investor Attorney Network, is investigating whether members of the board of directors of Nanosphere Inc (NASDAQ: NSPH) acted responsibly on behalf of investors’ profitability in the planned $77 million sale to Luminex Corporation (NASDAQ: LMNX).

On May 23, 2016, Nanosphere Inc (NASDAQ: NSPH) and Luminex Corporation (NASDAQ: LMNX) announced that they had entered into a merger agreement. Under the terms of the merger agreement, Luminex will offer Nanosphere shareholders $1.70 per share in cash for all outstanding shares.    

Based in Northbrook, Illinois, and founded in 1998 Nanosphere Inc develops molecular diagnostic tests that can lead to earlier disease detection, optimal patient treatment and improved healthcare economics.

The investigation focuses on whether NASDAQ: NSPH investors received the highest price and whether the directors of Nanosphere Inc acted in the best interest of Nanosphere Inc company and its shareholders.   

If you purchased Nanosphere Inc (NASDAQ: NSPH) prior to May 23, 2016, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185